Health

Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close.  The Company will host a conference call...

2019-06-11 19:00 13417

TauRx Recognized as a Technology Innovation Leader in the Neurodegenerative Disease Management Industry

ABERDEEN, Scotland and SINGAPORE, June 11, 2019 /PRNewswire/ -- TauRx, a leader in neurodegenerative disease research, today announced that it is the recipient of Frost & Sullivan's 2019 Asia Pacific Neurodegenerative Disease Management Technology Innovation Award.

2019-06-11 08:00 2016

Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device

PLYMOUTH MEETING, Pennsylvania, June 10, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the medical arm of the U.S. Defense Threat Reduction Agency (DTRA) will fund the further development of Inovio's new commercial intradermal delivery device. DTRA's Medical ...

2019-06-10 21:00 3003

Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization

This milestone marks a pivotal point in Avalon's pipeline, now allowing the company to enter its next phase of commercializing clinical-grade exosome products FREEHOLD, New Jersey, June 10, 2019 /PRNewswire/ -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based techn...

2019-06-10 20:00 7267

Ping An Good Doctor Launches Groundbreaking 'Private Doctor' Service

Strategic Move to Introduce Customized Mobile Medical Services SHANGHAI, June 10, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), the world's leading one-stop healthcare ecosystem platform, has launched the...

2019-06-10 12:32 9115

Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks

Abstracts 54-OR and 55-OR Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance® and Victoza® SAN FRANCISCO, June 8, 2019 /PRNewswire/ -- Findings presented today from two phase 3a clinic...

2019-06-08 23:45 2959

ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic

GLASGOW, Scotland, June 8, 2019 /PRNewswire/ -- Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in ju...

2019-06-08 07:01 4559

Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards

SINGAPORE, June 7, 2019 /PRNewswire/ -- Frost & Sullivan named some of Asia's leading companies recognized for their achievements in its recipients list for the Asia-Pacific Best Practices Awards earlier today. Mr. Shivaji Das, Partner & Asia-Pacific Managing Director at Frost & Sullivan noted t...

2019-06-07 23:23 10088

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...

2019-06-06 18:00 15873

HealthEngine celebrates new milestone for Australian health, recording one million bookings in a single month

PERTH, Australia, June 6, 2019 /PRNewswire/ -- HealthEngine has solidified its position as Australia's leading consumer healthcare platform, reaching one million monthly bookings in May 2019. CEO and Medical Dir...

2019-06-06 09:21 5776

Yichun to boost tourism industry development in Jiangxi

YICHUN, China, June 5, 2019 /PRNewswire/ -- The 2019 Jiangxi Tourism Industry Development Conference opened in Yichun City, East China'sJiangxi province on June 5. The annual event is an important platform for tourism cooperation of Jiangxi Province. Yichun, one of the most picturesque citi...

2019-06-05 18:31 4458

Poor Oral Health Severely Impacts Training and Athletic Performance, Says FDI World Dental Federation

GENEVA, June 5, 2019 /PRNewswire/ -- If they want to win, elite and amateur athletes need to make theiroral health a top priority. FDI World Dental Federation (FDI) couldn't agree more. Today the organization released a serie...

2019-06-05 09:00 2868

Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO

SUZHOU, China, June 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...

2019-06-05 08:00 5851

Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for Treatment of Bone Marrow Failure Syndromes

HOUSTON, June 4, 2019 /PRNewswire/ -- Cellenkos, Inc., announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure syndromes, including aplastic anemia, hypoplas...

2019-06-04 21:17 5718

RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer

Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need YANTAI, China, June 4, 2019 /PRNewswire/ -- R...

2019-06-04 21:00 5774

Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...

2019-06-04 20:17 16757

Medtec China will expand to 2 Halls in 2020 for the first time

SHANGHAI, June 4, 2019 /PRNewswire/ -- Medtec China 2019 will be held at Shanghai World Expo Exhibition and Convention Center September 25–27. This exhibition has continued its upward momentum trend -- the overall scale of the event is up by21%, and the area of exhibition booths commercially avai...

2019-06-04 19:11 6005

Genecare partners with Jupiter Chain to release a secure online genetic profiling platform

SINGAPORE, June 4, 2019 /PRNewswire/ -- Genetics testing is the core of preventive healthcare. Clients must first understand their genetic makeup to lower the risks of developing an illness or disease. A leading ASEAN company, Genecare, is one genetics testing company that allows clients to bette...

2019-06-04 09:00 4539

Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody...

2019-06-04 08:00 10670

Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of extended follow-up on sintilimab, the anti-PD-1 antibody that co-deve...

2019-06-04 08:00 10242
1 ... 554555556557558559560 ... 563